Residual 3D Vena Contracta Area following Transcatheter Tricuspid Valve Repair is independently associated with Patient Survival

J. L. Althoff (Köln)1, T. Gietzen (Köln)2, M. Schäfer (Köln)2, K. Finke (Köln)3, S. Baldus (Köln)3, C. Iliadis (Köln)2, R. Pfister (Köln)2, M. I. Körber (Köln)2
1Universitätsklinikum Köln Klinik III für Kardiologie, Angiologie, Pneumologie und Internistische Intensivmedizin Köln, Deutschland; 2Herzzentrum der Universität zu Köln Klinik III für Innere Medizin Köln, Deutschland; 3Herzzentrum der Universität zu Köln Klinik für Kardiologie, Angiologie, Pneumologie und Internistische Intensivmedizin Köln, Deutschland

Background:
Severe tricuspid regurgitation (TR) is associated with poor outcomes and affects a growing proportion of elderly patients. Emerging transcatheter approaches, such as tricuspid transcatheter edge-to-edge repair (T-TEER) and annuloplasty (TTVA), rely heavily on three-dimensional echocardiography for procedural guidance. While 3D vena contracta area (3D-VCA) has shown superior accuracy over conventional two-dimensional parameters in assessing TR severity, its predictive value and definitive cut-offs for transcatheter interventions remain unclear.

Methods:
This is the first retrospective analysis of residual 3D VCA in high-surgical-risk patients who underwent T-TEER or TTVA at a tertiary center in Germany (n=141). Echocardiographic data were acquired using standardized 2D transthoracic and 3D transesophageal protocols with offline analysis. The primary endpoint was 3-year survival.

Results:
The study cohort were predominantly women (68.3%), with a median age of 81 years (76–84). The median TRI-Score was 4 (3–6). Residual TR grade ≤II was achieved in 69% of procedures. Over a median follow-up period of 473 (375–891) days, univariate cox regression showed a significant association of 3D VCA and survival (HR 1.16 [1.02 – 1.33]; p=0.029). Via maximally selected rank statistics a cut-off value of >0.5 cm2 was determined. Patients with a postprocedural 3D VCA above this value showed significantly poorer survival (p<0.001). Different proposed cut-off-values for severe TR by several authors also showed significant differences in survival in this cohort (p=0.004 for 3D VCA >0.4 cm2 and >0.61 cm2, p<0.001 for >0.75 cm2). Conventional parameters effective regurgitation orifice area (EROA) ≥ 0.4 cm² and VC ≥ 7 mm showed no significant association with survival (log-rank test: p=0.46 and p=0.07, respectively). A 3D VCA cut-off of 0.2 cm2, differentiating mild from moderate TR, did not yield significant influence on 3-year survival (p=0.16).
Multivariate cox-regression analysis incorporating postprocedural 3D VCA (categorial cut-off 0.5 cm2, baseline NYHA level (I-IV), and TRI-SCORE (points), showed a significant association of 3D VCA and TRI-SCORE with survival with no such association for NYHA level (p=0.012, <0.001, and 0.34, respectively).

Conclusion:
In this study, postprocedural 3D VCA was independently associated with 3-year survival, and postprocedural 3D VCA >0.5 cm2 served as a meaningful cut-off value. In contrast, the conventional cut-off values for EROA and VC showed no significant associations with survival. Our findings reinforce the importance of maximizing procedural efficacy to improve patient outcomes and demonstrate a potential predictive value of 3D VCA assessment.